As a first-line treatment, NovoSeven® RT is 92% effective and recommended by an international consensus.
Effective bleed control for people with acquired hemophilia.
NovoSeven® RT is the only bypassing agent that is approved by the FDA for acquired hemophilia.

Effective bleed control for people with acquired hemophilia.
NovoSeven® RT is the only bypassing agent that is approved by the FDA for acquired hemophilia.

Proven to be effective.
![Acquired Hemophilia: NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) was 92% effective as first-line treatment](/content/dam/novonordisk/novoseven/what-does-it-treat/92-percent.png)
Lower volume means fast infusion.
Because it's a low-volume treatment, NovoSeven® RT takes 2 to 5 minutes to infuse.a
aAdminister as a slow bolus injection over 2 to 5 minutes, depending on the dose administered.
![low volume treatment of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])- 6.3ml](/content/dam/novonordisk/novoseven/what-does-it-treat/NovoSeven®-RT-low-volume-treatment.png)
![low volume treatment of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])- 6.3ml](/content/dam/novonordisk/novoseven/what-does-it-treat/NovoSeven®-RT-low-volume-treatment.png/jcr:content/renditions/mobile)
![Pie Chart: NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) takes 2 to 5 minutes to infuse](/content/dam/novonordisk/novoseven/what-does-it-treat/graphic-acquired-infusion.png)
bBased on the initial dose for a 70-kg patient with acute bleeding.
Established safety profile.
Recombinant manufacturing means NovoSeven® RT is made without any human blood or plasma, which minimizes the possibility of viral contamination. And in a clinical trial, 4% of patients with acquired hemophilia experienced adverse events (blood clots).

What if I need surgery or a procedure?
We understand that you have concerns about controlling bleeds if you ever need surgery or a procedure. The good news is that NovoSeven® RT is effective for preventing bleeds during and after surgery and procedures in people with acquired hemophilia.
Talk to your doctor for more information on the surgical use of NovoSeven® RT.
What about surgery and procedures?
Approved for surgical use and procedures for patients with acquired hemophilia.

Hear from people who
share your experience.

New to treatment? It's
easy to get started.
![Icon: 5-step purification process of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])](/content/dam/novonordisk/novoseven/cta/CTA-recombinant.jpg)